Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...

Indeed, a recent study published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology found a prolonged ...

Jake Sullivan, the outgoing national security adviser, is asking a panel of outside experts to examine the government’s ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.

Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postac ...

The COVID-19 outbreak in 2019 triggered measures to raise public awareness regarding pandemics and also led to fast-tracked ...

Diagnosing simultaneous infections of multiple respiratory viruses is challenging. Researchers from Korea have now addressed ...

When virologists took their first peek at XEC, the Covid-19 variant which started to become dominant in the autumn of 2024, ...

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, sore throat, loss of taste or smell, fatigue and body aches, headache, nausea ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ...